California to sue Lilly, other drug companies over insulin prices

California on Thursday announced it will sue the companies—including Indianapolis-based Eli Lilly and Co. (NYSE: LLY)—that make and promote most of the nation’s insulin, accusing them of scheming to illegally increase the price of the drug and demanding they return millions of dollars to some diabetics who state officials say were overcharged for the medicine they must have to survive.... Read More